Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Sharon Grundfest-Broniatowski, MD, FACS, has been a Staff Surgeon at Cleveland Clinic since 1982. She is also Associate Professor of Surgery at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Dr. Grundfest-Broniatowski is certified by the American Board of Surgery and the American Board of Colon and Rectal Surgery.
Her treatment interests include laparoscopic surgery, breast surgery, hernia surgery, gallbladder surgery, gastrointestinal surgery and pancreatic surgery. Dr. Grundfest-Broniatowski's research interests focus on bioartificial pancreas for diabetes, breast cancer and rehabilitation of paralyzed musculature.
She is a Fellow of the American College of Surgeons and the American College of Gastroenterology
and a member of the American Society for Colon and Rectal Surgery.
abdominal surgery, Advanced Laparoscopic Surgery, anti-reflux, as well as surgery of the gastrointestinal tract, biliary surgery, biliary system and splenectomy, breast, breast cancer, breast diagnostics, breast diseases, breast surgery, breast surgical oncology, colon surgery, gastrointestinal, gastrointestinal surgery, general surgery, general surgery and advanced laparoscopic surgery including laparoscopic colon, hepatobiliary and pancreatic surgery, hepatobiliary surgery, hernia repair, hernia repairs, hernia surgery, Hiatal Hernia, laparoscopic placement of CAPD catheters, laparoscopic surgery of hernias, major abdominal wall reconstruction, Minimally Invasive Surgery, pancreatic and biliary surgery, Pancreatic Cancer, Pancreatic Surgery, surgery of the gastrointestinal tract
Innovations & Patents
Award for Innovations in artificial organs: Opto-isolated pulse width modulated nerve stimulator for hemiparalysis of the face, 37th Annual Meeting of the ASAIO, Chicago, Ill., 4/26/91
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 12/16/2014, Dr. Grundfest-Broniatowski has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.